Key Documents
Gary Schoolnik
- Professor, Medicine - Infectious Diseases
- Professor, Microbiology & Immunology
Contact Information
- Clinical Offices
Infectious Diseases 300 Pasteur Dr B241 MC 5428 Stanford, CA 94305 Telephone Work (650) 723-8158 Fax (650) 723-1399
Clinical Focus
- Infectious Disease
- Infectious Diseases
Professional Education
- Board Certification: Infectious Disease, American Board of Internal Medicine (1976)
- Massachusetts General Hospital/Joslin Diabetes Center (1978) MA
- University of Washington School of Medicine (1976) WA
- Board Certification: Internal Medicine, American Board of Internal Medicine (1975)
- Massachusetts General Hospital/Joslin Diabetes Center (1974) MA
- Massachusetts General Hospital/Joslin Diabetes Center (1973) MA
- University of Washington School of Medicine-GME (1972) WA
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Gangagen
- Equity: Gangagen
- Service on Board of Directors: Gangagen
Research Interests
Structure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses
Publications
- Nucleic Acids Res. 2006; (8): 2438-44
- Science. 2006; (5782): 1944-6
- Microbes Infect. 2006; (4): 1132-40
- J Bacteriol. 2006; (3): 1049-59
- Proc Natl Acad Sci U S A. 2005; (34): 12200-5
- Science. 2005; (5755): 1824-7
- Tuberculosis (Edinb). 2004; (3-4): 256-62
- Tuberculosis (Edinb). 2004; (3-4): 218-27
- Proc Natl Acad Sci U S A. 2004; (8): 2524-9
- Nat Biotechnol. 2004; (5): 505-6; author reply 506-7
- Mol Microbiol. 2004; (2): 497-515
- J Exp Med. 2003; (5): 705-13
- J Bacteriol. 2003; (22): 6695-701
- Mol Microbiol. 2003; (4): 879-89
- Mol Microbiol. 2003; (3): 833-43
- J Bacteriol. 2003; (10): 3179-89
- J Exp Med. 2003; (5): 693-704
- Proc Natl Acad Sci U S A. 2003; (20): 11672-7
- J Exp Med. 2003; (7): 987-97
- Nature. 2002; (6889): 642-5
- Curr Opin Microbiol. 2002; (1): 20-6
- J Bacteriol. 2002; (13): 3457-65
- Mol Microbiol. 2002; (2): 365-74
- Adv Microb Physiol. 2002; 1-45
- Infect Immun. 2002; (7): 3371-81
- J Bacteriol. 2001; (16): 4848-59
- Methods Enzymol. 2001; 3-18
- Mol Microbiol. 2001; (2): 423-37
- J Exp Med. 2001; (8): 1123-40
- Genome Biol. 2001; (4): REPORTS4009
- J Bacteriol. 2001; (5): 1716-26
- Proc Natl Acad Sci U S A. 2001; (13): 7534-9
- Genome Biol. 2000; (3): REVIEWS1016
- Int J Tuberc Lung Dis. 2000; (12 Suppl 2): S189-93
- Microbiology. 2000; 1525-33
- Proc Natl Acad Sci U S A. 1999; (22): 12833-8
- Mol Microbiol. 1999; (4): 741-52
- Science. 1999; (5419): 1520-3
- Infect Immun. 1999; (10): 5455-62
- Proc Natl Acad Sci U S A. 1999; (7): 4028-33
- J Bacteriol. 1998; (4): 773-84
- Gene. 1998; (1-2): 107-17
- Science. 1998; (5372): 2114-8
- J Bacteriol. 1997; (5): 1591-7
- Mol Microbiol. 1996; (5): 963-75
- Vaccine. 1996; (16): 1560-8
- J Bacteriol. 1996; (9): 2613-28
- Mol Microbiol. 1996; (1): 87-100
- J Bacteriol. 1996; (22): 6555-63
- J Bacteriol. 1996; (1): 209-15
- J Infect Dis. 1995; (1): 170-6
- Vaccine. 1995; (3): 235-44
- Vaccine. 1995; (2): 142-50
- J Infect Dis. 1995; (1): 212-6
- Methods Enzymol. 1994; 271-82
- N Engl J Med. 1994; (24): 1703-9
- J Biol Chem. 1994; (24): 16610-7
- J Bacteriol. 1994; (10): 3085-8
- Mol Microbiol. 1993; (4): 563-75
- Am J Vet Res. 1993; (2): 248-53
- J Bacteriol. 1993; (22): 7391-403
- J Clin Invest. 1993; (3): 1117-8
- Obstet Gynecol. 1993; (4 Pt 1): 578-85
- N Engl J Med. 1993; (16): 1137-44
- J Clin Microbiol. 1993; (7): 1677-82
- Mol Microbiol. 1993; (5): 865-73
- Mol Microbiol. 1992; (18): 2589-97
- J Infect Dis. 1992; (5): 951-7
- N Engl J Med. 1992; (4): 231-5
- J Cell Biol. 1992; (1): 197-207
- Mol Microbiol. 1992; (18): 2725-32
- Science. 1991; (5032): 710-3
- J Exp Med. 1991; (5): 1167-77
- Infect Dis Clin North Am. 1991; (2): 265-75
- J Clin Invest. 1991; (6): 2132-41
- Am J Obstet Gynecol. 1991; (1): 67-71
- J Biol Chem. 1991; (17): 11037-43
- Mol Microbiol. 1990; (10): 1661-6
- J Exp Med. 1990; (3): 795-806
- Mol Microbiol. 1990; (7): 1119-28
- Adv Pharmacol. 1990; 221-85
- Bol Oficina Sanit Panam. 1990; (2): 93-9
- Bull Pan Am Health Organ. 1990; (2): 210-6
- Pediatr Res. 1990; (5): 507-13
- J Infect Dis. 1990; (6): 1252-6
- Methods Enzymol. 1989; 163-71
- Mol Microbiol. 1989; (1): 57-64
- EMBO J. 1989; (10): 3149-52
- Mol Microbiol. 1989; (10): 1379-83
- J Immunol. 1989; (12): 4227-31
- Mol Microbiol. 1989; (12): 1729-34
- Proc Natl Acad Sci U S A. 1988; (4): 1247-51
- Science. 1988; (4845): 1272-6
- J Exp Med. 1988; (3): 983-1002
- J Exp Med. 1988; (5): 1855-64
- J Exp Med. 1988; (3): 817-31
- J Bacteriol. 1988; (7): 3032-9
- J Infect Dis. 1988; (2): 332-42
- Nature. 1987 Feb 12-18; (6105): 625-8
- Nature. 1987 Dec 24-31; (6150): 763-5
- Proc Natl Acad Sci U S A. 1987; (11): 3673-7
- J Exp Med. 1987; (4): 1041-57
- Med Hypotheses. 1987; (3): 303-7
- Infect Immun. 1987; (9): 2052-6
- Antonie Van Leeuwenhoek. 1987; (6): 465-9
- Proc Natl Acad Sci U S A. 1987; (24): 8907-11
- Adv Exp Med Biol. 1987; 53-62
- Nature. 1986 Aug 14-20; (6080): 641-4
- Biochemistry. 1986; (24): 7854-66
- Proc Natl Acad Sci U S A. 1986; (23): 8888-92
- Proc Natl Acad Sci U S A. 1986; (22): 8585-8
- J Biol Chem. 1986; (3): 1470-6
- Ann Sclavo Collana Monogr. 1986; (1-2): 389-98
- Proc Natl Acad Sci U S A. 1986; (2): 483-7
- Infect Immun. 1986; (1): 320-6
- J Infect Dis. 1985; (5): 990-1001
- Adv Exp Med Biol. 1985; 247-73
- J Exp Med. 1985; (1): 145-59
- J Clin Invest. 1985; (2): 347-60
- Proc Natl Acad Sci U S A. 1985; (3): 915-9
- J Exp Med. 1985; (4): 705-17
- J Infect Dis. 1985; (5): 895-901
- J Exp Med. 1985; (6): 1539-53
- J Bacteriol. 1985; (1): 132-9
- Proc Natl Acad Sci U S A. 1985; (16): 5480-4
- J Comp Neurol. 1985; (1): 53-64
- N Engl J Med. 1985; (7): 414-20
- J Biol Chem. 1985; (23): 12528-34
- Eur J Biochem. 1985; (2): 315-21
- EMBO J. 1984; (13): 3165-75
- J Exp Med. 1984; (6): 1782-91
- J Exp Med. 1984; (4): 1253-8
- Infect Immun. 1984; (1): 251-9
- J Exp Med. 1984; (1): 208-21
- EMBO J. 1984; (5): 1159-65
- J Exp Med. 1984; (5): 1351-70
- Infect Immun. 1984; (2): 361-6
- J Neurosci. 1984; (10): 2581-9
- J Bacteriol. 1984; (1): 330-3
- J Infect Dis. 1984; (1): 83-9
- Infect Immun. 1984; (1): 353-8
- Prog Allergy. 1983; 314-31
- Prog Allergy. 1983; 189-202
- J Exp Med. 1983; (5): 1713-19
- Infect Immun. 1983; (3): 942-9
- Nature. 1982; (5874): 560-2
- Scand J Infect Dis Suppl. 1982; 46-51
- J Immunol. 1979; (5): 1771-9
- J Infect Dis. 1978; (2): 160-5
- Infect Immun. 1977; (1): 165-72
- J Infect Dis. 1977; S132-7
- J Clin Invest. 1976; (5): 1163-73